Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound cordyceps oral liquid is a traditional Chinese medicine (TCM) developed and manufactured by Yaodu Zhangshu Pharmaceutical, a subsidiary of the Renhe Group. It is an herbal formulation primarily composed of *Cordyceps* (often cultured mycelium) in combination with other traditional herbs. In the framework of TCM, the liquid is used to tonify the lungs and kidneys, replenish vital essence, and strengthen the immune system. It is clinically indicated for the treatment of chronic cough, asthma, and chronic bronchitis, as well as for recovery from general fatigue or weakness following illness. As a complex herbal mixture, it exerts multi-target effects on the respiratory and immune systems rather than acting on a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound cordyceps oral liquid.